|
Shinva Cricothyroid Instruments Set ZA101
Surgical instrument sets are bought as coordinated kits, where missing items or unclear article numbers can affect preparation and sterility workflows. The ZA101 listing provides a starting point for checking composition before quotation.
The Shinva Cricothyroid Instruments Set ZA101 is presented as an ENT surgical instrument set for hospital, operating-room, and specialist department use. Its listed configuration includes nine line items, supplied as a set rather than individual instruments.
The itemized contents include two scalpel handles, a curved tracheal dilating forceps, straight and curved Crile haemostatic forceps, three abdominal puncture needles in different sizes, and one pack of 15# scalpel blades. Each line carries an article number, description, unit, and quantity.
For procurement, the article numbers are the practical reference points. Buyers can compare the supplied list against department preference cards, existing tray layouts, and reprocessing instructions before confirming an order.
The input does not confirm materials, sterilization method, documentation, or packaging details. Those points require direct confirmation, along with minimum order quantity, lead time, shipping terms, and a formal quotation.
A mixed set such as this also raises inventory questions. Replacement blades, forceps, and puncture needles may follow different supply cycles, so the set’s long-term usability depends on component availability as much as initial price.
Why it matters:
The listed configuration is only the first check. Verification of article numbers, quantities, documentation, and lead times determines whether the set fits an existing ENT instrument workflow.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
ScientificChina is an independent commercial platform and is not affiliated with or endorsed by any Chinese government agency or public institution.
|
|